BDTX
Black Diamond Therapeutics Inc
Price:  
1.65 
USD
Volume:  
280,735.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BDTX Intrinsic Value

-491.43 %
Upside

Is BDTX undervalued or overvalued?

As of 2025-03-15, the Intrinsic Value of Black Diamond Therapeutics Inc (BDTX) is -6.46 USD. This BDTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.65 USD, the upside of Black Diamond Therapeutics Inc is -491.43%. This means that BDTX is overvalued by 491.43%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

1.65 USD
Stock Price
-6.46 USD
Intrinsic Value
Intrinsic Value Details

BDTX Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -6.46 - -6.46 -6.46 -491.43%
P/E (13.15) - (29.89) (21.06) -1376.1%
DDM - Stable (9.29) - (37.01) (23.15) -1502.8%
DDM - Multi (0.17) - (0.51) (0.26) -115.5%

BDTX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 93.37
Beta 2.78
Outstanding shares (mil) 56.59
Enterprise Value (mil) 69.95
Market risk premium 4.60%
Cost of Equity 10.44%
Cost of Debt 5.00%
WACC 7.05%